W2. An International perspective focusing on similarities and differences related to substance use disorders in Australia, UK, Portugal and USA

Abstract:

According to the World Drug Report (2018) the scope of drugs
and drug markets are increasing and spreading globally. The
international community needs to step up its responses to
cope with these challenges. Members of IntNSA, representing
Australia, England, Portugal, and the United States, will
come together to share their experience of the similarities
and differences between their countries that impact on the
successes/failures related to substance use disorders. Topics
covered will include historical perspectives, access to care, harm
reduction approaches, treatment modalities, impact of COVID
19, among others. As this workshop will be online topics will be
divided into ‘learning units’ of 1.5 hours in duration. An opportunity
for participants to take “comfort breaks” of 30 mins in between
each unit of learning will be provided.

Learning objectives:

• Participants will be able to identify the historical
  perspective of each country and understand how
  history impacts treatment of substance use disorders
  today (1.5 hrs) (12:00 EST)
• Participants will be able to describe and learn different
  concepts and practices of access to treatment for
  substance use disorders (1.5 hrs) (2:00 pm EST)
• Participants will be able to define harm reduction and
  learn different concepts and meaning in the practice of
  harm reduction (1.5 hrs) (4:00pm EST
• Participants will be able to identify at least one current
  and future trends in treatment of substance use
  disorders in the identified countries. (1.5 hrs) (6:00pm
  EST)
• Participants will describe how COVID-19 has impacted
  the care and practice of those with substance use
  disorders (1.5hrs) (8:00pm EST)

Authors

• Theresa Fay-Hillier, DrPH, MSN, PMHCNS-BC Drexel University, USA
• Roseann Regan, PhD, APRN, BC Gwynedd University, USA
• Dana Murphy-Parker, MS, APRN, PMHNP-BC, CARN-AP, FIAAN, Front Range Clinic, USA
• Adrian Jugdoval, PGDip, PGCAP, BSc (Hons), PGCertHE, RGN, RMN,
  NMP, TCH, FHEA, University of West London, Middlesex University, UK
• Adam Searby, PhD, RN, Melbourne, Australia
• Paulo Rosario De Carvalho Seabra, PhD, MSN, BSN, Portugal